This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by The Baruch Padeh Medical Center, Poriya.
Recruitment status was:  Recruiting
Information provided by:
The Baruch Padeh Medical Center, Poriya Identifier:
First received: March 1, 2006
Last updated: August 10, 2011
Last verified: January 2009
Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

Condition Intervention Phase
Acute Myocardial Infarction Drug: Tirofiban Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by The Baruch Padeh Medical Center, Poriya:

Primary Outcome Measures:
  • mortality [ Time Frame: immidiately ]

Secondary Outcome Measures:
  • TIMI flow [ Time Frame: 24 hours ]
    feeling better

Estimated Enrollment: 200
Study Start Date: January 2006
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Tirofiban

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital

Exclusion Criteria:

  • women less than 50 years old and 80 years old, bleeding tendency, stroke in the past
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00300833

Contact: Yonathan Hasin, Professor 97246652648

Cardiovascular Division, The Baruch Padeh Medical Center, Poriya, Recruiting
Tiberias, Israel, 15208
Magen David , Recruiting
Tiberias, Israel
Contact: Sergay Krablikov, Dr         
Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Study Chair: Menachem Naheer The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel
  More Information

Responsible Party: Menachem Nahir, The baruch Padeh Medical center Identifier: NCT00300833     History of Changes
Other Study ID Numbers: Aggrastat in AMI.CTIL
Study First Received: March 1, 2006
Last Updated: August 10, 2011

Additional relevant MeSH terms:
Myocardial Infarction
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Platelet Aggregation Inhibitors processed this record on August 16, 2017